Global Large Volume Parenteral (LVP) Market Overview 2023-2028

The global large volume parenteral (LVP) market size reached US$ 9.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.37% during 2023-2028.

Large volume parenteral (LVP) is a single-dose injection packaged in a glass bottle or a flexible container after sterilization through heating. It comprises an active ingredient, water-miscible or non-aqueous vehicle, and added substances, such as preservatives, buffers, antioxidants, surfactants, tonicity adjusters, and antimicrobial agents. It is widely available as irrigating solutions, peritoneal dialysis, blood derivatives, contrast agents, and drug premixes. It is injected via the skin or other external boundary tissue to directly administrate the active drug substances in the organs, blood vessels, tissues, or lesions.

Global Large Volume Parenteral (LVP) Market Trends and Drivers:

At present, the increasing utilization of LVPs in heart surgery to prevent ischemic injury to the myocardium during reperfusion and the blood flow supply restriction represents one of the key factors contributing to the market growth. Besides this, the rising prevalence of premature births and malnutrition around the world is strengthening the market growth. Apart from this, the increasing utilization of LVPs for treating esophageal obstruction, gastrointestinal (GI) diseases, cancer, and ulcers are propelling the growth of the market. Moreover, the rising incidence of various non-communicable diseases among individuals worldwide is offering lucrative growth opportunities to industry investors. Furthermore, the growing demand for effective, safe, and quick methods of drug administration among patients is offering a positive market outlook.

Global Large Volume Parenteral (LVP) Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are:  Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.

The report segmented the market on the basis of region, type, volume, application and end users.

Breakup by Type:

• Soft Bag LVP
• Plastic Bottle LVP
• Glass Bottle LVP

Breakup by Volume:

• 100 ML – 250 ML
• 250 ML – 500 ML
• 500 ML – 1000 ML
• 1000 ML – 2000 ML
• 2000 ML and More

Breakup by Application:

• Therapeutic Injections
• Fluid Balance Injections
• Nutritious Injections

Breakup by End Users:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

If you want the latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800